High-Purity SNAP-8 (Acetyl Octapeptide-3) Peptide Powder

Sales manager:Nora
whatsapp：+12817797656
Email:lisa@qtsbio.com

snap-8 is an investigational weight-management medication being developed by Eli Lilly, a leading pharmaceutical company recognized for its advances in diabetes and obesity treatment. As a novel incretin-based therapy targeting metabolic pathways, retatrutide has demonstrated substantial effects on body weight reduction and metabolic health in clinical studies, making it a promising candidate for the treatment of obesity and related chronic conditions.

Beyond its potential applications in obesity and metabolic disorders, preclinical research has explored several possible effects of retatrutide and related incretin-based therapies on neurological and psychological conditions. However, these potential applications remain investigational and require further clinical validation.

Potential effects on depression and anxiety:
Preclinical studies have suggested that incretin-based therapies may exhibit antidepressant- and anxiolytic-like effects. These findings indicate the possibility that such therapies may have future applications in the management of depression and anxiety disorders, although their efficacy and safety for these conditions have not yet been established in humans.

Potential neuroprotective effects:
Research has investigated whether incretin-based therapies may provide neuroprotective benefits that could be relevant to neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. Further studies are needed to determine whether these findings can translate into meaningful clinical outcomes.

Potential effects on cognitive function:
Animal studies have reported improvements in certain aspects of learning and memory following treatment with incretin-related therapies. These findings suggest a potential role in supporting cognitive health, although evidence from well-controlled human clinical trials remains limited.

Potential applications in chronic pain:
Preclinical research has explored the possible analgesic and anti-inflammatory properties associated with incretin-based therapies. While these findings are of scientific interest, retatrutide is not currently an established treatment for chronic pain, and its potential therapeutic role in this area requires further investigation.

1. snap-8 has attracted significant attention in the pharmaceutical field, particularly in research related to weight management and metabolic disorders.

   snap-8 is a synthetic peptide-based therapeutic compound.

   snap-8 acetate functions as a multi-receptor agonist targeting the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R).

   Through activation of glucagon receptors and modulation of related metabolic pathways, retatrutide acetate promotes increased energy expenditure and contributes to significant reductions in body weight.

   snap-8 acetate can be utilized as a research tool in studies investigating obesity and related metabolic conditions.

1. How to make an order?
Send me message and let me know what you need with quantity , then i will calculate to you

2. What's the lead time and shipping ways?
We will delivery to the package by UPS, FEDEX, DHL paket and YANWEN express to you after receive your payment, it would take around 5-15 days to your address.

3. How do i keep the peptides when i receive it ?
Peptides in the form of lyophilized powder can be transported at room temperature by vacuum packaging, while polypeptides in the dissolved state need to be refrigerated at 2°C - 8°C. For long-term storage, peptides should be stored in the form of lyophilized powder store at -20°C or -80°C in a sealed container with desiccant, which can avoid the degradation of peptides to the greatest extent.

4. What's the payment methods?
We could accept pay through Wise, Bank Transfer, Alipay USDT and BTC.